Hong Kong Biotech Stock News

Ingdan (SEHK:400) has just wrapped up FY 2025 with first half revenue of C¥6.7b and basic EPS of C¥0.09, setting the tone for a year where margins and earnings quality are firmly in focus. Over the last few reporting periods, the company has seen revenue move from C¥4.3b in 1H 2024 to C¥5.8b in 2H 2024 and then to C¥6.7b in 1H 2025. Basic EPS shifted from C¥0.08 to C¥0.06 and then to C¥0.09, leaving investors weighing a higher top line against thinner net profit margins and considering what...

Haichang Ocean Park Holdings (SEHK:2255) opened FY 2025 with first half revenue of C¥686.3 million and a basic EPS loss of C¥0.036, against trailing twelve month revenue of C¥1.7 billion and a trailing EPS loss of C¥0.117. Over the past year, the company has seen revenue move from C¥799.8 million in 1H 2024 to C¥686.3 million in 1H 2025, while basic EPS shifted from a loss of C¥0.010 in 1H 2024 to a loss of C¥0.036. This keeps the focus firmly on how quickly margins can recover from current...

China Petroleum & Chemical (SEHK:386) has released its full-year 2025 results, reporting lower sales, revenue, and net income, along with a reduced final dividend and a change in President, all drawing fresh attention to the stock. See our latest analysis for China Petroleum & Chemical. The results announcement and leadership reshuffle come after a 30 day share price return showing a 15.62% decline and a year to date share price return showing a 2.34% decline, while the 1 year total...

Earnings and Dividend Moves Draw Attention China Resources Building Materials Technology Holdings (SEHK:1313) has attracted fresh attention after reporting higher full year 2025 net income alongside a proposed increase in its final cash dividend. The company posted CNY 21,054.77 million in sales and CNY 479.36 million in net income for 2025, and the board recommended a final dividend of HK$0.024 per share, up from HK$0.01 a year earlier. See our latest analysis for China Resources Building...

What China Lesso’s Latest Earnings Mean For Shareholders China Lesso Group Holdings (SEHK:2128) has just released full year 2025 results, with sales of CNY 24,314.93 million and net income of CNY 1,261.64 million, both below the prior year’s levels. Basic and diluted earnings per share from continuing operations came in at CNY 0.41, compared with CNY 0.55 a year earlier. This puts the focus squarely on how the business is adjusting its cost base and growth priorities. See our latest analysis...

Persistence Resources Group (SEHK:2489) has released its FY 2025 numbers, reporting fourth quarter revenue of C¥178.5 million and basic EPS of C¥0.009559, with these figures set against a share price of HK$1.04. The business reported quarterly revenue of C¥134.6 million in Q4 2024 and C¥178.5 million in Q4 2025, while basic EPS over that same period moved from C¥0.009452 to C¥0.009559. Trailing twelve month EPS stands at C¥0.053 on revenue of C¥628.8 million, providing a basis for investors...

3D Medicines (SEHK:1244) has released its FY 2025 first half figures, reporting revenue of C¥209.2 million and a basic EPS loss of C¥0.36 per share, underscoring that the business is still in loss-making territory. Over recent periods, the company has seen revenue range from C¥206.4 million in 1H 2024 to C¥239.2 million in 2H 2024, while basic EPS moved between losses of C¥0.42 and C¥0.32 per share. This gives investors a clearer view of how revenue scale and per share losses have tracked...

SOHO China (SEHK:410) has just posted its FY 2025 first half numbers, recording revenue of C¥689.8 million and a basic EPS loss of C¥0.0176 per share, keeping investors focused squarely on the earnings line. Over the past three reported halves, revenue has moved from C¥799.4 million in 1H 2024 to C¥741.1 million in 2H 2024 and then to C¥689.8 million in 1H 2025. Basic EPS has stayed in loss-making territory across the same stretch, providing a backdrop of margin pressure for interpreting the...

OSL Group (SEHK:863) has just posted its FY 2025 numbers, with second half revenue of HK$293.3 million and a basic EPS loss of HK$0.49, while trailing twelve month figures show revenue of HK$488.8 million and a basic EPS loss of HK$0.57. The company has seen revenue move from HK$250.9 million in the second half of FY 2024 to HK$293.3 million in the second half of FY 2025, alongside a shift from basic EPS of HK$0.11 to a basic EPS loss of HK$0.49. This sets up a results season that puts...

Capinfo (SEHK:1075) has reported its FY 2025 first half results with revenue of CN¥680.8 million and basic EPS of CN¥0.033, while trailing 12 month figures show revenue of about CN¥1.6 billion and EPS of CN¥0.068 as the business moved from prior losses to a profit. Over recent periods, revenue has shifted from CN¥538.1 million in 1H FY 2024 to CN¥934.3 million in 2H FY 2024 and CN¥680.8 million in 1H FY 2025, with basic EPS swinging from a loss of CN¥0.083 in 1H FY 2024 to CN¥0.035 in 2H FY...

Bank of Jiujiang (SEHK:6190) has just closed out FY 2025 with fourth quarter revenue of C¥1.2b and a net loss of C¥63.8m, setting the stage for a year that looks very different from its longer term earnings record. Over the past year, revenue on a trailing twelve month basis has moved from C¥4.3b at the end of 2024 to C¥4.7b at the end of 2025, while trailing EPS has shifted from C¥0.14 to C¥0.17, and investors now have to weigh a 17.7% net profit margin against a five year period where...

Super Hi International Holding FY 2025 earnings snapshot Super Hi International Holding (SEHK:9658) has reported its FY 2025 numbers with fourth quarter revenue of US$232.1 million and basic EPS of US$0.01, while trailing twelve month revenue reached US$850.3 million with EPS of US$0.06. Over recent periods, revenue has moved from US$210.1 million in Q4 FY 2024 to US$232.1 million in Q4 FY 2025, with quarterly EPS shifting from a loss of US$0.02 per share to a profit of US$0.01. This sets up...

Minieye Technology (SEHK:2431) has reported its FY 2025 first half results with revenue of C¥345.7 million and a basic EPS loss of C¥0.38, while trailing twelve month figures show revenue of C¥763.5 million and a basic EPS loss of C¥0.69. Over recent half year periods the company has seen revenue move from C¥236.7 million in 1H 2024 to C¥417.8 million in 2H 2024 and then to C¥345.7 million in 1H 2025. Net income has remained in loss territory at C¥108.1 million, C¥108.4 million, and C¥151.6...

Qingling Motors (SEHK:1122) has reported its FY 2025 first half with revenue of C¥2.1b and a basic EPS loss of C¥0.014, keeping the focus squarely on how far the business still needs to travel to reach consistent profitability. Over the past three reported halves, revenue has moved between C¥2.0b and C¥2.1b while basic EPS losses have ranged from C¥0.005 to C¥0.017. This gives a clear view of how the top line has held steady against a backdrop of ongoing net losses. For investors, this latest...

China Travel International Investment Hong Kong (SEHK:308) has released its FY 2025 first half figures, reporting revenue of HK$1,973.7 million and a net loss excluding extra items of HK$86.9 million, which translated into basic EPS of a HK$0.016 loss. The company has seen half year revenue move from HK$2,136.0 million in 1H 2024 to HK$2,490.4 million in 2H 2024 and then to HK$1,973.7 million in 1H 2025. Basic EPS shifted from HK$0.011 in 1H 2024 to HK$0.008 in 2H 2024 before turning to a...

Setting the Scene: China Cinda Asset Management’s FY 2025 Earnings Snapshot China Cinda Asset Management (SEHK:1359) opened FY 2025 with first half revenue of about CN¥10.3b and basic EPS of CN¥0.046, as trailing twelve month EPS reached roughly CN¥0.05 on revenue of about CN¥35.1b, setting a clear benchmark for how the business is currently performing. The company has seen revenue move from CN¥8.9b and EPS of CN¥0.043 in the first half of 2024 to CN¥10.3b and EPS of CN¥0.046 in the first...

5100 Xizang Glacier (SEHK:1115) has just posted its FY 2025 first half results, reporting revenue of C¥168.5 million and basic EPS of C¥0.0079, with the latest trailing twelve month figures showing revenue of C¥357.9 million and EPS of C¥0.0183. Over recent periods, the company has seen revenue move from C¥138.8 million in 1H FY 2024 to C¥168.5 million in 1H FY 2025, while EPS shifted from C¥0.0021 to C¥0.0079 across the same halves, alongside a trailing twelve month swing from an EPS loss of...

China Daye Non-Ferrous Metals Mining (SEHK:661) has just reported first half FY 2025 revenue of C¥29.3 billion with a basic EPS loss of C¥0.000553, setting the tone for a year in which investors are closely watching how top line scale translates into bottom line consistency. Over the past three reported halves, revenue has moved from C¥32.8 billion in 1H FY 2024 to C¥25.0 billion in 2H FY 2024 and now C¥29.3 billion in 1H FY 2025. EPS has shifted from C¥0.004327 to a loss of C¥0.002081 and...

Legend Holdings (SEHK:3396) has posted its FY 2025 results with first half revenue of about C¥285.2b and basic EPS of C¥0.30, set against a share price of HK$8.45 as investors weigh what the rebound in profitability means for the story from here. The company has seen revenue move from roughly C¥238.0b in 1H FY 2024 to C¥285.2b in 1H FY 2025, while basic EPS shifted from C¥0.12 and a loss of C¥0.06 across the two halves of FY 2024 to C¥0.30 in the latest half, alongside a trailing twelve month...

Bayzed Health Group (SEHK:2609) has reported its FY 2025 first half with revenue of C$574.7 million and a basic EPS loss of C$0.020948, setting the tone for another period where the top line and per share performance remain firmly in focus. Over the recent periods, the company has seen revenue move between C$570.9 million and C$617.9 million per half while basic EPS has ranged from a loss of C$0.00161 to C$0.022396, underscoring a pattern of meaningful sales with persistent, if fluctuating,...

Fusen Pharmaceutical (SEHK:1652) has posted its FY 2025 first half results with revenue of C¥111.3 million and a basic EPS loss of C¥0.031, while trailing twelve month figures show revenue of C¥241.0 million and a basic EPS loss of C¥0.237 as losses have expanded at 79.7% per year over the past five years. Over recent periods the company has seen revenue move from C¥196.3 million and a basic EPS loss of C¥0.050 in 1H FY 2024 to C¥129.7 million and a basic EPS loss of C¥0.205 in 2H FY 2024,...

Zall Smart Commerce Group (SEHK:2098) has just posted its FY 2025 numbers with first half revenue of about CN¥90.9b and basic EPS of CN¥0.0078, while trailing twelve month EPS came in at CN¥0.0142 on revenue of roughly CN¥185.0b, underpinned by a 124.8% rise in earnings over the last year. Over recent reporting periods, the company has seen revenue move from CN¥68.3b in 1H FY 2024 to CN¥94.1b in 2H FY 2024 and then to CN¥90.9b in 1H FY 2025. Basic EPS shifted from CN¥0.0040 to CN¥0.0064 and...

EuroEyes International Eye Clinic (SEHK:1846) has posted its FY 2025 first half results with total revenue of HK$377.1 million and basic EPS of HK$0.12, setting the tone for how the rest of the year may shape up. The company has seen revenue move from HK$368.4 million in 1H 2024 to HK$377.1 million in 1H 2025, while basic EPS shifted from HK$0.13 to HK$0.12 over the same period. Trailing 12 month basic EPS sits at HK$0.24 on revenue of HK$724.4 million. With a trailing net profit margin of...

Fengyinhe Holdings (SEHK:8030) has reported its FY 2025 first half results with revenue of CNY 71.1 million and basic EPS of CNY 0.084629, alongside trailing twelve month revenue of CNY 128.1 million and EPS of CNY 0.176535, set against year-over-year earnings growth of 83.6%. Over recent halves, the company has seen revenue move from CNY 79.9 million in 1H 2024 to CNY 57.0 million in 2H 2024 and CNY 71.1 million in 1H 2025. Basic EPS shifted from CNY 0.327943 to CNY 0.092448 and then CNY...